Nettoinventarwert (NAV)
| 79.26 USD | USD | % |
|---|
| Vortag | USD | Datum | 31.10.2026 |
Kairos Long Short Equity Strategy Series 569 Notes due 2045 Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 185.82% | |
| 21Shares Stacks ETP | CH1258969042 | 154.88% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 130.82% | |
| 21Shares Arbitrum ETP | CH1304867463 | 115.43% | |
| 21Shares Injective Staking ETP | CH1360612134 | 84.05% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 139.35% | |
| 21Shares Raydium ETP | CH1480821391 | 115.87% | |
| 21Shares Injective Staking ETP | CH1360612134 | 100.05% | |
| 21Shares Uniswap ETP | CH1135202096 | 91.61% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 81.05% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 93.41% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 88.97% | |
| 21Shares Raydium ETP | CH1480821391 | 31.07% | |
| 21Shares Uniswap ETP | CH1135202096 | 21.59% | |
| 21Shares Injective Staking ETP | CH1360612134 | 17.79% |
Fundamentaldaten
| Valor | |
| ISIN | XS3238271764 |
| Emittent | Alveo Wealth Management LLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 28.11.2025 |
| Kategorie | Aktien Long/Short Sonstige |
| Währung | USD |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 04.11.2026 |
Anlagepolitik
So investiert der Kairos Long Short Equity Strategy Series 569 Notes due 2045: "The Investment Strategy deploys a bottom-up fundamental approach to security selection, taking concentrated directional positions, both long and short, primarily in public equity securities that trade on US stock exchanges with a medium to long-term outlook. A factor-based quantitative overlay strategy may be implemented to control systematic exposures from common relationships between securities."